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Protocol
AbstrAct
Introduction Young adults with diabetes often report 
dissatisfaction with care and have poor diabetes-related 
health outcomes. As diabetes prevalence continues to rise, 
group-based care could provide a sustainable alternative 
to traditional one-to-one consultations, by engaging young 
people through life stage-, context- and culturally-sensitive 
approaches. In this study, we will co-design and evaluate 
a group-based care model for young adults with diabetes 
and complex health and social needs in socioeconomically 
deprived areas.
Methods and analysis This participatory study will include 
three phases. In phase 1, we will carry out a realist review 
to synthesise the literature on group-based care for young 
adults with diabetes. This theory-driven understanding 
will provide the basis for phase 2, where we will draw on 
experience-based co-design methodologies to develop 
a new, group-based care model for young adults (aged 
<25 years, under the care of adult diabetes services). In 
phase 3, we will use a researcher-in-residence approach 
to implement and evaluate the co-designed group clinic 
model and compare with traditional care. We will employ 
qualitative (observations in clinics, patient and staff 
interviews and document analysis) and quantitative methods 
(eg, biological markers, patient enablement instrument and 
diabetes distress scale), including a cost analysis.
Ethics and dissemination National Health Service 
ethics approval has been granted (reference 17/NI/0019). 
The project will directly inform service redesign to 
better meet the needs of young adults with diabetes 
in socioeconomically deprived areas and may guide a 
possible cluster-randomised trial, powered to clinical and 
cost-effectiveness outcomes. Findings from this study may 
be transferable to other long-term conditions and/or age 
groups. Project outputs will include briefing statements, 
summaries and academic papers, tailored for different 
audiences, including people living with diabetes, clinicians, 
policy makers and strategic decision makers.
Registration details PROSPERO (CRD42017058726).
InTroducTIon
Diabetes has been described as one of the 
most significant global public health chal-
lenges of our time.1 Over the last four 
decades, the global prevalence of both type 
1 and type 2 diabetes has increased sharply to 
reach an estimated 8.5% in the adult popula-
tion in 2014.2 In the UK, recent figures place 
the number of adults living with diabetes 
at 4.5 million, of whom around 1 million 
remained undiagnosed in 2016.3 This has 
raised the cost of diabetes care to 10% of 
the annual National Health Service (NHS) 
budget and has highlighted an urgent need 
to investigate different ways of delivering 
diabetes prevention and care.4 5
Strengths and limitations of this study
 ► This study will draw on the strengths of group-based 
care to address the complex needs of young adults 
(aged 16–25 years) living with diabetes in ethnically 
diverse, socioeconomically deprived backgrounds.
 ► Cultural, developmental and practical considerations 
will be taken in account as part of iterative co-design 
and participatory evaluation of the new care model.
 ► A theory-driven, realist review of the literature 
will further inform the co-design process and will 
strengthen the transferability of findings.
 ► The project does not intend to generate an effect 
size, but findings may inform the design of a future 
cluster-randomised controlled trial.
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Despite growing emphasis on improving diabetes 
prevention and care in the adult population, less atten-
tion has been paid to young people living with diabetes. 
In England and Wales, over 27 000 children and young 
people with diabetes receive care in paediatric diabetes 
units,6 and increasing numbers (poorly recorded) of 
adolescents and young adults are living with the condi-
tion. Young people constitute an important group for 
early intervention as good self-management practices 
internalised at a young age could persist throughout 
adulthood and reduce the risk of lifetime complica-
tions, prevent early mortality and lower costs for the 
health service.7 8 Young people of today will grow up to 
constitute the estimated 642 million living with diabetes 
worldwide in 2040.1 Yet, in 2014/2015, only one quarter 
of children and young people with diabetes in England 
and Wales achieved recommended blood glucose control 
(HbA1c <58 mmol/mol as per the National Institute for 
Health and Care Excellence 2004 target) and a simi-
larly low proportion received all recommended care 
processes, with high variability between care providers.6 
This is reinforced by research showing that mortality 
among young adults with diabetes in the UK is worse 
than in other European countries and rose significantly 
between 1990 and 2010.9 Diabetes is also known to have 
serious consequences in those diagnosed in childhood: 
diabetes-related complications (such as kidney and eye 
diseases) were seen in 1 in 3 of those with type 1 diabetes, 
and 3 in 4 with type 1 diabetes in their early 20s, within 8 
years of diagnosis.10
Barriers to accessing healthcare for younger people 
have been well described, including lack of develop-
mentally appropriate consultations, fear of being judged 
and stigmatised, lack of equitable access to services and 
diabetes-related distress.11 12 Published data show that 
young adults report the worst NHS experience of any age 
group and have distinct healthcare needs and priorities 
compared with other age groups.13 14 This may be even 
more important for young people from socioeconom-
ically deprived areas who achieve worse blood glucose 
control and present with more complications compared 
with more affluent areas and for those in ethnic minority 
groups who are disproportionately affected by type 2 
diabetes.6 15
The TOGETHER project will employ participatory 
methods to co-design, deliver and evaluate a model for 
diabetes care that addresses the needs of young people 
(aged 16–25 years) from socioeconomically deprived 
backgrounds. This model will draw on the strengths of 
group-based care, involving consultations and educa-
tion sessions delivered by a multidisciplinary team and 
attended concurrently by a group of patients, in contrast 
to traditional one-to-one, consultant-led care.
Previous research has shown that group-based care in 
adults with diabetes resulted in better glycaemic control, 
problem-solving ability and quality of life and reduced 
time commitment for clinicians, compared with stan-
dard one-to-one consultations.16 17 Systematic reviews on 
group care for diabetes showed additional benefits for 
clinical and patient-reported outcomes.18 19 Further trials 
applying group-based care to diabetes and other condi-
tions are underway with some work focusing on children 
and adolescents.20–22 However, these studies are limited 
to health but not social care needs, they have not utilised 
co-design processes or extensive user engagement and 
they are primarily targeting patient groups other than 
adolescents and young adults (aged 16–25 years) in ethni-
cally diverse, socioeconomically deprived backgrounds.
Our research seeks to address these uncertainties, 
including whether group-based care could be success-
fully adapted for this younger patient group and whether 
rigorous co-design of a new model of care can enhance 
acceptability and engagement. Furthermore, we will 
explore whether the positive impact of group-based 
education such as DAFNE (Dose-Adjustment for Normal 
Eating - a structured education programme for people 
withtype 1 diabetes) and DESMOND (Diabetes Education 
and Self Management for Ongoing and Newly Diagnosed 
- a structured education programme for people with type 
2 diabetes)23 24 as well as supporting evidence from studies 
of peer support25 26 could be harnessed in group clinics 
for young adults to improve engagement with diabetes 
care and self-management in the wider context of indi-
vidual, family, peer and social influences.27–29 This work 
will extend previous learning on the role of peer support 
groups and mentoring as a way to address complex health 
and social care issues.29–31
The TOGETHER project will be driven by the following 
aims and research questions:
Aims
1. To explore the scope, feasibility, impact and potential 
scalability of group clinics for young adults with 
diabetes and complex health and social care needs.
2. To contribute to NHS service re-design and improve 
care for people from hard-to-reach groups with long-
term conditions.
research questions
1. How and to what extent might an innovative, co-
designed group clinic-based care model meet the 
complex health and social needs of young people with 
diabetes?
2. Could a group approach help support diabetes 
self-management? If so, what do the experiences of 
participants, the functioning of the group and the 
wider context in which the new model takes place tell 
us about its mechanisms of action?
3. What are the feasibility, acceptability, costs and impact 
on outcomes of introducing group clinics for their 
users and stakeholders? What is the organisational 
impact of this model to the NHS and other 
stakeholders?
4. What would be the optimal size and study design of 
a cluster-randomised controlled study to evaluate 
the clinical benefit and cost-effectiveness of offering 
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group clinics to all suitable young adults with 
diabetes? What other factors should be considered 
when planning such an RCT (eg, factors relating to 
patient characteristics, existing models of service 
delivery, acceptability and mechanisms of action of 
group clinics on clinical outcomes)?
MeThods And AnAlysIs
Theoretical and conceptual framework
Development and evaluation of new models of healthcare 
are frequently hindered by lack of robust, appropriate 
and explicit theoretical frameworks.32 The TOGETHER 
project will draw on a broad set of substantive social 
science and educational theories, including:
 ► ecological theories on supported self-management33–35
 ► work on patient expertise and experiential 
knowledge in practice36 37
 ► critical education theory and experiential 
learning38 39
 ► the concept of interdependency in figurational 
sociology40 41
The study will also draw on key theoretical and prac-
tical approaches to participatory research that allow 
researchers, practitioners and service users to learn 
together for the benefit of service re-design:42 43
(A) Participatory co-design
The group clinics intervention will be iteratively co-de-
signed using a participatory approach to ensure cultural, 
developmental and practical relevance; enhance recruit-
ment and retention; and attempt to instigate system 
change and support sustainability.44
(B) Participatory research and evaluation
 The ‘researcher in residence’ model will be adopted, as 
a practical manifestation of a participatory approach to 
research and evaluation. The model has three defining 
features: the researcher is an integral member of the front-
line implementation team, their theoretical and practical 
contribution is explicit, along with their role to negotiate 
different bodies of expertise.45 The embedded researcher 
will bridge the qualitative and quantitative evaluations, 
helping to include practitioner and patient views into the 
design and feeding back early findings to stakeholders. 
The model has been applied successfully in a number of 
different settings.45 46 A balance will be sought between 
how the ‘researcher in residence’ will be contributing 
to co-design and implementation in practice, and how 
this involvement will be translated in theoretical terms to 
increase transferable learning.
research plan
The study will be conducted in three phases. A realist 
review will synthesise findings from existing literature to 
understand how group clinics may work for young adults 
with diabetes and other complex needs (phase 1). This 
understanding will be used to support a participatory 
co-design process with service users (phase 2). Following 
implementation of group-based care, the model will be 
evaluated using qualitative methods and quantitative 
methods (phase 3).
The timeline of the project and the processes followed 
are illustrated in figure 1. The project is funded by the 
National Institute for Health Research Health Services 
and Delivery Research programme (ref. no. 15/25/20) 
to run for 3 years, from December 2016 to November 
2019.
Phase 1: realist review
Following the Realist And Meta-narrative Evidence 
Syntheses: Evolving Standards (RAMESES), we will 
undertake a realist review to understand ‘what works, for 
whom, under what circumstances’ in group clinics for 
young adults with diabetes.47–49 The review will enable us 
to synthesise data from existing qualitative, quantitative 
and mixed-methods studies relevant to this topic area. 
Findings will support co-design, allow context-sensitive 
tailoring of the intervention and guide implementation 
and evaluation.50
Figure 1 Overview of study design.
group.bmj.com on July 14, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
4 Papoutsi C, et al. BMJ Open 2017;7:e017363. doi:10.1136/bmjopen-2017-017363
Open Access 
The output of the review will be a realist programme 
theory expressed in the form of Context–Mechanism–
Outcome Configurations (CMOCs) (see Glossary in 
supplementary files for definitions). We anticipate being 
able to examine specific mechanisms by which group 
clinics are deemed to ‘work’, including the potential for 
the group to generate a sense of greater security for indi-
viduals and to create norms, to harness social conformity 
and peer influence positively to change behaviour and to 
facilitate experiential learning and social support for self-
care and engagement. To do this, we will build on recently 
completed realist reviews in the area51 52 and will extend 
their findings for a young adult population with complex 
needs in socioeconomically deprived backgrounds.
The synthesis will follow five iterative stages: (A) 
locating existing theories, (B) searching for evidence, (C) 
selecting articles, (D) extracting and organising data and 
(E) synthesising the evidence and drawing conclusions.53
(A) Locating existing theories
An exploratory search of the literature along with articles 
provided by content experts will allow the development 
of an initial programme theory, that is, a set of provi-
sional assumptions about how group clinics work for 
young adults with diabetes. This programme theory will 
continue to be refined throughout the review.
(B) Searching for evidence
The formal search strategy will be structured with the 
help of an information specialist and will be tested in 
MEDLINE to reach appropriate sensitivity and specificity. 
Free-text and indexing search terms will include those 
used by previous systematic reviews.51 52 We will search the 
following databases: Embase, MEDLINE, MEDLINE-in-
process, PsycINFO, Web of Science, CENTRAL, Cochrane 
Database of Systematic Reviews, HTA database and 
ASSIA. Relevant studies will also be identified by hand 
searching, forward and backward citation tracking of key 
sources, contribution of key experts and grey literature 
where relevant.54 Results will be exported to Endnote for 
de-deduplication using automated and manual checking.
To respond to emerging findings (eg, on the impor-
tance of peer influence), we will carry out a second search 
as the review progresses to ensure we have covered all 
areas critical to continued engagement of young people in 
group clinics. This will allow us to progressively focus the 
review and enhance the explanatory depth of the analysis. 
Refinement of the programme theory will be discussed in 
research, co-design and project advisory meetings. This 
will allow us to link the review to practical questions that 
are critical in real world settings and provide added value 
to service delivery.
(C) Screening and selecting articles
Studies will be included if they focus on the introduc-
tion and delivery of group-based medical visits, group 
education and similar care delivery models for young 
people with diabetes. All study designs will be included 
across healthcare and community settings. Studies will be 
excluded if they focus solely on populations with consid-
erable differences to young adults, for example, older 
people or very young children, if they discuss self-man-
agement education without a component of group 
interaction or if they are written in languages other than 
English. Inclusion and exclusion criteria will continue to 
be refined as needed throughout the review, according 
to best practice for realist reviews.47 Articles remaining 
after full-text screening will be classified according to 
their potential to contribute to programme theory. At the 
point of inclusion based on relevance, the trustworthiness 
and rigour of each study will be assessed as appropriate 
for each study design.47 A 10% random subsample of 
screening decisions will be reviewed by a second reviewer 
for consistency.
(D) Extracting and organising data
The main reviewer will read all articles classified as highly 
relevant, will extract descriptive study characteristics and 
will carry out manual coding for immersion in the data. 
Full texts will be uploaded on to NVivo V.11 (qualita-
tive data management software) to continue coding in 
broad conceptual categories and to subsequently apply 
a realist logic of analysis. This means we will work itera-
tively to identify sections of text related to Contexts (C), 
Mechanisms (M), Outcomes (O) and the configurations 
between them (CMOCs), until theoretical saturation has 
been reached. In doing this, we will seek to interpret and 
explain how young adults with diabetes reason about and 
respond (by way of ‘hidden’ mechanisms) to ‘resources’ 
becoming available through group clinics and to identify 
the specific contexts or circumstances where these mech-
anisms are more likely to be ‘triggered’. Again, a 10% 
random subsample of coded articles will be reviewed by 
a second reviewer for consistency and disagreements will 
be solved by discussion.
(E) Synthesising the evidence and drawing conclusions
Coded data on CMOCs will be exported into Word docu-
ments to develop the final programme theory and the 
narrative of the synthesis. By moving between data and 
programme theory, we will be able to refine our expla-
nations of why certain patterns seem to be occurring 
in certain contexts and under specific circumstances, 
related to group-based care. This will involve drawing on 
substantive theory to enhance the plausibility and coher-
ence of the arguments. The final programme theory 
will consist of evidence-informed propositions, drawing 
on the literature, substantive theory, professional and 
patient expertise. These propositions will form the basis 
for co-design and implementation of group-based care in 
phase 2.
Phase 2: co-design and implementation
(A) Co-design
Health services often have limited success in changing 
health-related behaviours unless they take into account 
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the perspectives and priorities of their patients and the 
staff providing that service.55 This is particularly true of 
patient groups (eg, those defined by age, ethnicity or 
deprivation) who are poorly served and/or reached by 
standard care models. The experience-based co-design 
process56 will bring together patients and staff into every 
stage of the project, supported by experienced co-design 
facilitators, allowing direct collaboration with the team 
who will be implementing the care models and regular 
opportunities for review and iteration. In this way, the 
co-design process will facilitate the development, review 
and refinement of user-centred services and care path-
ways. Co-design will be preceded by a brief national 
scoping exercise via professional groups to investigate 
current use and perceptions of group clinics in diabetes 
care, along with a formative evaluation to map existing 
local services for young adults with diabetes at two NHS 
Trusts.
We will recruit 15–20 young adults living with diabetes, 
members of their support network (eg, parents) and 
other stakeholders (eg, youth workers and healthcare 
professionals) to help us develop the group clinic model 
by drawing on their personal experience in co-design 
workshops. Participants will be identified via the diabetes 
service at Barts Health NHS Trust (Newham University 
Hospital), GP practices and lay support groups. Written 
information will be given explaining the study and what 
participation would involve. Co-design workshops will 
take place in community-based facilities in the London 
Borough of Newham, a deprived, ethnically diverse popu-
lation with a high prevalence of long-term conditions and 
reduced life expectancy compared with UK averages.57
(B) Implementation
Once the co-designed model of care is established, all 
patients aged 16–25 years attending the Barts Health NHS 
Trust (Newham University Hospital) diabetes service will 
be offered the opportunity to attend group clinics. The 
16–25 year age range incorporates adolescents and young 
adults with both type 1 and type 2 diabetes who are under 
the care of the multidisciplinary adult diabetes service 
during and after transition from paediatric services. The 
adult diabetes service involves close integrated working 
with local primary care and will facilitate referral into the 
group clinic model from GP care where relevant. We aim 
to recruit 80 young adults to this part of the research, 
using additional sites if required, giving a sample size that 
will enable sufficient development and evaluation of the 
new group clinic model, will allow feasibility testing and 
will guide a future, scaled-up cluster-randomised trial.
Each group clinic is expected to comprise around 8–10 
individuals (young adults living with diabetes) and will 
be run by the Newham diabetes team, with support from 
related health and social care organisations. The content 
of these group clinics will be determined by the co-de-
sign process and the needs of the group but is likely to 
include a range of support for diabetes self-management 
(as already provided in current one-to-one clinics) and 
extend to a wider set of issues, including other health and 
social care needs and parental input where required. The 
content and running of the group clinics is anticipated 
to evolve during the 2 years in which they will run, due 
to refinements and revisions guided by ongoing co-de-
sign and participant feedback. The anticipated design of 
the group clinic model will follow two phases: (1) addi-
tion: where the group clinics are offered in addition to 
routine clinical care, and (2) substitution: to be rolled 
out after the addition model of group clinics has been 
implemented and considered to be running smoothly 
and safely by their participants, the clinical and research 
team and the project advisory group.
Phase 3: evaluation
(A) Qualitative methods
Qualitative methods will allow the research team to 
develop a better understanding of the contexts and 
mechanisms by which group clinics do, or do not, work. 
They will provide rich data on the experiences of patients 
in group-based care and their attitudes to managing 
their diabetes and interactions with health services in 
the wider context of individual, family, employment and 
other social factors. We will adopt a process-oriented and 
formative approach to the evaluation, negotiating the 
analysis and interpretation of the emerging evidence 
as implementation unfolds in order to maximise the 
impact of the intervention. Comparison of group clinics 
with traditional services will allow the relative merits of 
the new service to be better understood, given the estab-
lished evidence that improvement interventions are more 
successful when practitioners can see a relative advantage 
over current practice.58
data collection
Data will be generated through a number of methods:
 ► Individual and group interviews with service users, 
group facilitators and practitioners: semistructured 
interviews will be conducted with a sample of service 
users including those who drop out of the groups 
and those who receive standard care. Sample size will 
be determined by data saturation and is expected to 
comprise between 20 and 30 participants. Purposive 
sampling will ensure variation in salient characteristics 
including type of diabetes, type of clinic attended, 
ethnicity and language. Sampling will also be 
driven by the findings of the realist review, as to the 
characteristics and circumstances that play a role in 
the success or failure of the group clinic model. Group 
interviews will be conducted with all group clinic 
facilitators and practitioners delivering standard care. 
With participant consent, interviews will be audio-
recorded and transcribed. Bilingual health advocates 
will be used where necessary.
 ► Observations of group clinics and standard care: 
a sample of group clinics will be observed using a 
flexible pro forma to capture clinic characteristics 
such as session content, context, group dynamics 
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and facilitation style. A sample of standard care 
consultations will be observed as a point of 
comparison. Detailed field notes will be kept during 
observations and audio recordings may be taken with 
participant consent. Group clinics and standard care 
appointments will be sampled to capture maximum 
variation (eg, morning/evening clinics in different 
areas).
 ► Documents: all documentation produced during co-
design sessions, steering group meetings and group 
clinics will be collected for analysis. Service users 
and group facilitators will be asked to document 
their experiences inside and outside of clinics using 
photos, videos, other visual representations (eg, 
diagrams and drawings) and/or reflective journals.
Data analysis
All data will be analysed thematically using an iterative 
process of inductive and deductive coding. An initial list 
of codes will be generated a priori based on the realist 
review, the co-design stage and our research questions. 
Codes will be added to this initial list inductively as neces-
sary. Data will be managed using NVivo V.11.
In combination with thematic analysis, the embedded 
researcher will apply a realist logic of analysis to the data 
to refine the realist programme theory deriving from the 
review in phase 1. The programme theory will provide a 
platform for combining qualitative and quantitative data, 
primarily in relation to how quantitative outcomes can 
be linked to qualitatively described processes of change. 
This will allow us to address the question of how and why 
group clinics may work differently compared with stan-
dard care.
Emerging findings will be discussed with the wider 
research and co-design group so that the analysis will be 
co-created with practitioners and service users. Rigour 
will be enhanced by checking for negative cases that chal-
lenge emerging interpretations of the data.
(B) Quantitative methods
The detailed qualitative evaluation of the new care model 
will be complemented by a quantitative evaluation, which 
will investigate the potential impact of group clinics on 
clinical outcomes, processes and costs. Definitive eval-
uation of the impact of group clinics is not possible 
within this study as the intervention is not yet sufficiently 
developed, nor will it be delivered at a scale powered to 
investigate differences in clinical outcomes. The quantita-
tive analysis will therefore (1) provide an early indication 
of the potential effects of group clinics on engagement 
and acceptability via attendance rates, measures of patient 
enablement and through use of the Problem Areas in 
Diabetes (PAID) scale,59–61 (2) investigate change in 
biological markers of diabetes control (eg, HbA1c) to 
guide sample size calculations for a future trial, (3) test 
feasibility of collecting service-level, resource (eg, staff 
contact and non-contact time), activity and process data 
for future unit-level comparisons in a cluster-randomised 
trial and (4) estimate costs associated with groups clinics 
compared with standard care.
The cost analysis will collate data on resource use 
(including routine and unscheduled care use) and will 
apply national unit costs to estimate staffing, capital and 
running costs related to running the standard versus 
group clinics at service level. Further analysis will look at 
the potential impact on use of other services and asso-
ciated costs, and thus the extent to which the group 
clinic model substitutes for, rather than adds to, stan-
dard care. This in turn will provide an early indication of 
any potential for efficiency savings for the NHS. To best 
inform a future trial, all resource use and cost data will be 
presented in both aggregated and disaggregated forms 
and for different scenarios, for example, group clinic 
costs according to variations in attendance rates.
data analysis
There will be different types of quantitative analysis of 
clinical outcomes and patient enablement:
 ► Intention to treat: simple descriptive statistics will 
be used to compare clinical outcomes among young 
adults with diabetes who were invited to attend the 
group clinics with controls from the same clinic over 
the previous year.
 ► Comparison of baseline characteristics, clinical 
outcomes and measures of patient enablement 
among patients who receive the intervention (n=80) 
with those at additional external young adult diabetes 
clinics (n=60) where the group clinics will not be 
implemented. The first stage of this process will 
complement qualitative findings on which patients 
are most attracted by the idea of group clinics. 
We will compare baseline sociodemographic and 
clinical characteristics of those who accept versus 
those who decline the opportunity to participate in 
group clinics. We will then use longitudinal data to 
compare the trajectories of clinical and enablement 
measures over the following year for individuals 
in the accept versus decline groups (difference in 
difference analysis).
 ► Unit-level data of clinical outcome (and indirect 
clinical outcome) data collected from additional 
external young adult diabetes clinics and National 
Diabetes Audit data (published annually by NHS 
Digital). This data analysis will inform a future 
scaled-up cluster-randomised controlled trial of 
group clinics by (1) testing the feasibility of unit-
level data collection, (2) identifying differences 
in the case mix of patients attending young adult 
diabetes clinics, and (3) characterising the clinical 
and process outcomes of young adults with diabetes 
under the care of different units.
ethics, safety and dissemination
Ethics and safety
The study has been approved by the Office for Research 
Ethics Committees Northern Ireland (reference 17/
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NI/0019). Standard rules apply for data security, confi-
dentiality and information governance. Informed consent 
will be sought for ethnographic observations during group 
clinics, interviews and for accessing routinely collected 
NHS data on participants. Confidentiality and privacy 
between group clinic participants will be a priority, and 
all participants in the group clinics will be asked to sign 
a code of conduct to ensure that personal information is 
not shared outside of the group.
dissemination plan and project outputs
Dissemination will be an ongoing process throughout the 
project, including activity at the outset to raise awareness 
of the project, at the mid-point to sustain interest and 
to feed back to participants and at the end and beyond 
to share learning. Our dissemination plan will build on 
our participatory approach to identify relevant audiences 
and maximise impact. We expect to target the following 
groups:
 ► project participants, user groups and local staff
 ► wider stakeholder community (including clinical 
networks)
 ► policy makers, strategic decision makers and funders
 ► academic community
The products needed to target these audiences will vary. 
We will write regular reports summarising our research 
activity and outputs, and these will be available via 
publicly accessible portals. We will prepare user-friendly 
versions of the main findings, briefing statements and 
policy summaries. Academic outputs will include journal 
articles in peer-reviewed, open access journals and confer-
ence presentations.
dIscussIon
The challenge of improving outcomes for young adults 
with diabetes is particularly evident in ethnically diverse 
areas with high levels of socioeconomic deprivation and 
with an increasing burden of type 1 and type 2 diabetes. 
Traditional models of diabetes care, based on one-to-one 
clinic appointments with health professionals, do not 
meet the needs of these populations consistently, who 
may see their medical care as only one issue in a complex 
pattern of health and social care priorities. Although the 
ability to self-manage long-term conditions is increasingly 
considered to be the optimal means to achieve good 
health outcomes, this can lead to power struggles between 
patient and provider.62 There is a need to co-design and 
evaluate new care models that address diabetes care in 
the context of these wider needs and increasing demands, 
to offer alternative support in attaining self-management 
goals and engagement and to improve the experience 
and clinical outcomes of people living with diabetes.
As previous work has shown, group-based care requires 
‘reallocation of tasks, roles, and resources and a change 
in providers' attitudes from the traditional prescriptive 
approach to a more empathic role of facilitator’.63 This 
research will explore the different mechanisms that may 
or may not allow group clinic participants to engage 
with care that better suits their needs and improves their 
health outcomes. We will draw on previous literature to 
consider a range of potentially relevant factors: prior 
engagement with health services; appointment dura-
tion, frequency and flexibility; congruent social, peer 
and cultural contexts; and closer integration with other 
health and social care providers.
This study spans the innovation stage (co-design of a new 
service model) and early testing stage (evaluation of the 
acceptability, feasibility, costs and mechanisms of action of 
group clinic models).64 In contrast to studies that start with 
a clear idea of the intervention and evaluate the impact 
of introducing this intervention, we do not yet know the 
optimal role of, or the best way to implement, group clinics, 
especially among these patient groups in this geographical 
context. The care model for young adults with diabetes we 
propose to develop will evolve during the course of our 
study to ensure it is context sensitive and fit for purpose. 
For these reasons, our evaluation framework will be largely 
developmental combining qualitative and quantitative 
methods to best address our research questions. Project 
outcomes are expected to inform the potential design of a 
future cluster-randomised controlled trial to evaluate the 
impact of group clinics on clinical outcomes and cost-ef-
fectiveness.
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